MAPT and Alzheimer disease: Consistent with this finding, analysis of longitudinal data from the Alzheimer’s Disease Neuroimaging Initiative cohort showed that women had greater hippocampal atrophy and faster cognitive decline in the presence of AD biomarkers (Cerebrospinal fluid levels Aβ1-42 and total tau) compared to men [67].